NCT01326104 2025-04-27
Re-MATCH
University of Florida
Phase 2 Completed
Clinical Trials
8 trialsNCT03150862 2025-02-04
A Study Assessing Pamiparib With Radiation and/or Temozolomide (TMZ) in Participants With Newly Diagnosed or Recurrent Glioblastoma
BeiGene
Phase 1/2 Completed
NCT02798406 2021-07-15
CAPTIVE
DNAtrix, Inc.
Phase 2 Completed
NCT00001686 2020-09-10
Evaluation, Treatment, and Natural History of Children and Young Adults With Cancer or Rare Diseases
National Institutes of Health Clinical Center (CC)
Completed
NCT01614132 2020-03-31
NOA-07
University of Regensburg
Phase 1/2 Completed
NCT02197169 2018-07-16
TARGET-I
DNAtrix, Inc.
Phase 1 Completed
NCT00831844 2015-03-30
Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors
National Cancer Institute (NCI)
Phase 2 Completed
NCT00513162 2012-09-19
Valproate and Etoposide for Patients With Neuronal Tumors and Brain Metastases
M.D. Anderson Cancer Center
Phase 1 Completed